Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression
<p>Abstract</p> <p>Background</p> <p>Prevention of bladder cancer recurrence is a central challenge in the management of this highly prevalent disease. The histone deacetylase inhibitor valproic acid (sodium valproate) has anti-angiogenic properties and has been shown t...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2490/12/21 |